Espinoza Octavio: insider trades.
Espinoza Octavio reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($9.2M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Espinoza Octavio
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Ligand Pharmaceuticals Inc (LGND) | Officer · Chief Financial Officer | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Ligand Pharmaceuticals Inc | M | 16,179 | $52.84 | 43,875 | Form 4 |
| 2026-08-12 | Ligand Pharmaceuticals Inc | M | 3,348 | $68.74 | 59,337 | Form 4 |
| 2026-08-12 | Ligand Pharmaceuticals Inc | M | 7,171 | $57.22 | 55,989 | Form 4 |
| 2026-08-12 | Ligand Pharmaceuticals Inc | S | 31,641 | $292.07 | 27,696 | Form 4 |
| 2026-08-12 | Ligand Pharmaceuticals Inc | M | 2,074 | $70.04 | 45,949 | Form 4 |
| 2026-08-12 | Ligand Pharmaceuticals Inc | M | 2,869 | $55.75 | 48,818 | Form 4 |
| 2026-06-30 | Ligand Pharmaceuticals Inc | J | 17 | $160.71 | 27,696 | Form 4 |
Questions
What stock did Espinoza Octavio buy or sell?
Espinoza Octavio reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($9.2M), across 1 company.
Is Espinoza Octavio the same person as other filers with this name?
This page covers SEC CIK 1905248 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/espinoza-octavio-1905248.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.